Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00015002 · ClinicalTrials.gov registry record · Phase 3
Repeat Antenatal Steroids Trial
A Phase 3 study, sponsored by The George Washington University Biostatistics Center.
- Terminated
- Registry status
- Phase 3
- Development phase
- 486
- Enrollment target
NCT00015002: Clinical Trial Phase 3 study, sponsored by The George Washington University Biostatistics Center.
NCT00015002 is a Phase 3 study that was terminated before completion, run by The George Washington University Biostatistics Center. The registered enrollment target is 486 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (37% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00015002, a Phase 3 study, was terminated before completion, sponsored by The George Washington University Biostatistics Center.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 486 participants
- Enrollment target
Study Summary
A course of steroids given to a mother who is in labor with a premature fetus will reduce the risk of the premature infant dying or having serious complications. This trial will test whether more than one course of antenatal steroids is more beneficial or risky to the infant than a single course.
Interventions
- DRUG Betamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 486 participants |
| Start Date | 2000-03 |
| Est. Completion | 2007-03 |
| Phase | Phase 3 |
Why NCT00015002 stopped before completion
NCT00015002 is an interventional study that assigns participants to a tested intervention. The registered 486 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (37% lower).
The record links to 0 conditions, and to 1 intervention - of which Betamethasone is the first listed.
NCT00015002 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00015002 about?
NCT00015002 is a clinical study titled "Repeat Antenatal Steroids Trial". A course of steroids given to a mother who is in labor with a premature fetus will reduce the risk of the premature infant dying or having serious complications. This trial will test whether more than one course of antenatal steroids is more beneficial or risky to the infant than a single course.
What is the current status of trial NCT00015002?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 486 participants. The study started on 2000-03. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00015002?
The interventions under investigation include: Betamethasone (DRUG).
Who is sponsoring clinical trial NCT00015002?
This trial is sponsored by The George Washington University Biostatistics Center, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00015002's enrollment target sits among peer trials
486 789th of 2000 higher than 1,211 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06420531 · 486 participants · NA
Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial
- NCT07097142 · 486 participants · Phase 3
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- NCT06948435 · 487 participants · Phase 3
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
- NCT06952530 · 487 participants · Phase 3
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia